CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 359 enrolled / 359 target
Drug / intervention
Educational Videoother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05472714
NCT05472714N/ACompletedHigh Momentum (6.2/mo)Completion was 15mo ago

Integration of Multimodal Cancer Predisposition Genetic Counseling Practices Within the Pediatric Oncology Setting: Video Intervention for Newly Diagnosed Families Undergoing Genetic Testing

Children's Hospital of Philadelphia·interventional·Posted Jul 25, 2022·Updated Jun 16, 2026

In Brief

A clinical study evaluating Educational Video for Genetic Disease and Cancer. Completed, enrolled 359 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

Develop and evaluate the acceptability, feasibility, and preliminary efficacy of an informational video on paired tumor/normal testing for children and adolescents with a new diagnosis of cancer, tumors or other diagnosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 25, 2022
Enrollment StartSep 10, 2021
Primary CompletionMar 22, 2025
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 3.9 years ago

Arms & Interventions

Without Videono_intervention

In year 1, investigators will recruit families of patients receiving the current standard-of-care approach to tumor-normal genetic testing with provider based education.

With Videoexperimental

In year 2, investigators will recruit families of patients receiving the updated standard-of-care approach to tumor-normal genetic testing with provider based education and an educational video.

Other: Educational Video

Interventions

Educational Videoother

Investigators will develop an informational video to be presented within one week of diagnosis of a tumor to those referred for tumor normal paired genetic testing.